<!DOCTYPE html><html lang="en" class="dark"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1"/><link rel="preload" href="/_next/static/media/e4af272ccee01ff0-s.p.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="stylesheet" href="/_next/static/css/8d323862949ffad9.css" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" href="/_next/static/chunks/webpack-d2cf98d9cef4ff37.js"/><script src="/_next/static/chunks/ceb5afef-fd730bca4742d10d.js" async=""></script><script src="/_next/static/chunks/156-5c70558397be49ef.js" async=""></script><script src="/_next/static/chunks/main-app-f896963268641fe0.js" async=""></script><script src="/_next/static/chunks/863-822c2cde35e02348.js" async=""></script><script src="/_next/static/chunks/app/layout-fb78cfc571d4c3d6.js" async=""></script><title>Unloxcyt Market Survey - Interactive Presentation</title><meta name="description" content="Comprehensive market analysis of Cosibelimab-ipdl for advanced cSCC"/><meta name="next-size-adjust"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule=""></script></head><body class="__className_f367f3 h-1080px w-1920px"><!--$!--><template data-dgst="BAILOUT_TO_CLIENT_SIDE_RENDERING"></template><!--/$--><div class="relative overflow-hidden w-[1920px] h-[1080px] bg-gradient-to-br from-slate-900 to-slate-700 text-white"><div class="flex flex-col w-full h-full"><div class="flex-none bg-slate-800/90 p-6 flex items-center gap-4"><svg xmlns="http://www.w3.org/2000/svg" width="48" height="48" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-users text-blue-400"><path d="M16 21v-2a4 4 0 0 0-4-4H6a4 4 0 0 0-4 4v2"></path><circle cx="9" cy="7" r="4"></circle><path d="M22 21v-2a4 4 0 0 0-3-3.87"></path><path d="M16 3.13a4 4 0 0 1 0 7.75"></path></svg><h1 class="text-6xl font-bold text-white">Competitive Landscape Analysis</h1></div><div class="flex-1 min-h-0 flex flex-col p-8 gap-6"><div class="flex-none"><h2 class="text-4xl font-bold text-white mb-2">Direct Competition: Advanced cSCC Treatment Market</h2><p class="text-2xl text-gray-300">Unloxcyt enters a market dominated by established PD-1 inhibitors with proven track records</p></div><div class="flex-1 min-h-0 overflow-hidden"><div class="bg-slate-800/90 rounded-lg overflow-hidden h-full"><table class="w-full h-full"><thead><tr class="bg-slate-700 border-b-2 border-blue-400"><th class="text-2xl font-bold text-white p-4 text-left">Product</th><th class="text-2xl font-bold text-white p-4 text-left">Company</th><th class="text-2xl font-bold text-white p-4 text-left">Mechanism</th><th class="text-2xl font-bold text-white p-4 text-left">Approval Year</th><th class="text-2xl font-bold text-white p-4 text-left">Metastatic cSCC ORR</th><th class="text-2xl font-bold text-white p-4 text-left">Key Advantage</th><th class="text-2xl font-bold text-white p-4 text-left">Weakness</th></tr></thead><tbody><tr class="bg-slate-800 border-l-4 border-purple-400"><td class="text-2xl p-4 font-bold text-purple-400">Unloxcyt</td><td class="text-2xl p-4">Sun Pharma</td><td class="text-2xl p-4">PD-L1 + ADCC</td><td class="text-2xl p-4">2024</td><td class="text-2xl p-4 font-bold text-green-400">47%</td><td class="text-2xl p-4 text-green-300">First PD-L1, ADCC activity</td><td class="text-2xl p-4 text-orange-300">Late market entry</td></tr><tr class="bg-slate-700/50"><td class="text-2xl p-4 font-bold">Keytruda</td><td class="text-2xl p-4">Merck</td><td class="text-2xl p-4">PD-1</td><td class="text-2xl p-4">2020</td><td class="text-2xl p-4">35%</td><td class="text-2xl p-4 text-green-300">Market leader, brand trust</td><td class="text-2xl p-4 text-orange-300">Lower ORR vs Unloxcyt</td></tr><tr class="bg-slate-800"><td class="text-2xl p-4 font-bold">Libtayo</td><td class="text-2xl p-4">Regeneron</td><td class="text-2xl p-4">PD-1</td><td class="text-2xl p-4">2018</td><td class="text-2xl p-4">Variable</td><td class="text-2xl p-4 text-green-300">First-mover, durability data</td><td class="text-2xl p-4 text-orange-300">Limited differentiation</td></tr><tr class="bg-slate-700/50"><td class="text-2xl p-4 font-bold">Opdivo</td><td class="text-2xl p-4">Bristol-Myers</td><td class="text-2xl p-4">PD-1</td><td class="text-2xl p-4">2014 (other)</td><td class="text-2xl p-4">N/A for cSCC</td><td class="text-2xl p-4 text-green-300">Broad oncology portfolio</td><td class="text-2xl p-4 text-orange-300">Not cSCC-specific</td></tr></tbody></table></div></div><div class="flex-none bg-slate-800/90 p-6 rounded-lg border border-slate-700"><h3 class="text-3xl font-bold text-white mb-4">Competitive Positioning Insights</h3><div class="grid grid-cols-1 gap-4"><div class="flex items-start gap-3"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-circle-check-big text-blue-400 mt-1"><path d="M21.801 10A10 10 0 1 1 17 3.335"></path><path d="m9 11 3 3L22 4"></path></svg><p class="text-xl"><strong>Market Concentration:</strong> Top 3 brands captured 91% of global PD-1/PD-L1 sales in 2021</p></div><div class="flex items-start gap-3"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-circle-check-big text-blue-400 mt-1"><path d="M21.801 10A10 10 0 1 1 17 3.335"></path><path d="m9 11 3 3L22 4"></path></svg><p class="text-xl"><strong>Differentiation Opportunity:</strong> Unloxcyt&#x27;s PD-L1 mechanism and ADCC provide legitimate clinical differentiation</p></div><div class="flex items-start gap-3"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-circle-check-big text-blue-400 mt-1"><path d="M21.801 10A10 10 0 1 1 17 3.335"></path><path d="m9 11 3 3L22 4"></path></svg><p class="text-xl"><strong>Market Size Justification:</strong> $1B+ U.S. cSCC market supports multiple successful competitors</p></div></div></div></div><div class="flex-none p-4 text-right"><p class="text-xl text-gray-400">5</p></div></div></div><script src="/_next/static/chunks/webpack-d2cf98d9cef4ff37.js" async=""></script><script>(self.__next_f=self.__next_f||[]).push([0]);self.__next_f.push([2,null])</script><script>self.__next_f.push([1,"1:HL[\"/_next/static/media/e4af272ccee01ff0-s.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n2:HL[\"/_next/static/css/8d323862949ffad9.css\",\"style\"]\n"])</script><script>self.__next_f.push([1,"3:I[5616,[],\"\"]\n5:I[6146,[],\"\"]\n6:I[4411,[],\"\"]\n7:\"$Sreact.suspense\"\n8:I[7256,[\"863\",\"static/chunks/863-822c2cde35e02348.js\",\"185\",\"static/chunks/app/layout-fb78cfc571d4c3d6.js\"],\"KeyboardNavigation\"]\n9:I[5407,[\"863\",\"static/chunks/863-822c2cde35e02348.js\",\"185\",\"static/chunks/app/layout-fb78cfc571d4c3d6.js\"],\"SlideNavigation\"]\nb:I[7141,[],\"\"]\nc:[]\n"])</script><script>self.__next_f.push([1,"0:[\"$\",\"$L3\",null,{\"buildId\":\"DkpgZd6XOJjDaY981EGFp\",\"assetPrefix\":\"\",\"urlParts\":[\"\",\"pages\",\"5\"],\"initialTree\":[\"\",{\"children\":[\"pages\",{\"children\":[\"5\",{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],\"initialSeedData\":[\"\",{\"children\":[\"pages\",{\"children\":[\"5\",{\"children\":[\"__PAGE__\",{},[[\"$L4\",[\"$\",\"div\",null,{\"className\":\"relative overflow-hidden w-[1920px] h-[1080px] bg-gradient-to-br from-slate-900 to-slate-700 text-white\",\"children\":[\"$\",\"div\",null,{\"className\":\"flex flex-col w-full h-full\",\"children\":[[\"$\",\"div\",null,{\"className\":\"flex-none bg-slate-800/90 p-6 flex items-center gap-4\",\"children\":[[\"$\",\"svg\",null,{\"xmlns\":\"http://www.w3.org/2000/svg\",\"width\":48,\"height\":48,\"viewBox\":\"0 0 24 24\",\"fill\":\"none\",\"stroke\":\"currentColor\",\"strokeWidth\":2,\"strokeLinecap\":\"round\",\"strokeLinejoin\":\"round\",\"className\":\"lucide lucide-users text-blue-400\",\"children\":[[\"$\",\"path\",\"1yyitq\",{\"d\":\"M16 21v-2a4 4 0 0 0-4-4H6a4 4 0 0 0-4 4v2\"}],[\"$\",\"circle\",\"nufk8\",{\"cx\":\"9\",\"cy\":\"7\",\"r\":\"4\"}],[\"$\",\"path\",\"kshegd\",{\"d\":\"M22 21v-2a4 4 0 0 0-3-3.87\"}],[\"$\",\"path\",\"1da9ce\",{\"d\":\"M16 3.13a4 4 0 0 1 0 7.75\"}],\"$undefined\"]}],[\"$\",\"h1\",null,{\"className\":\"text-6xl font-bold text-white\",\"children\":\"Competitive Landscape Analysis\"}]]}],[\"$\",\"div\",null,{\"className\":\"flex-1 min-h-0 flex flex-col p-8 gap-6\",\"children\":[[\"$\",\"div\",null,{\"className\":\"flex-none\",\"children\":[[\"$\",\"h2\",null,{\"className\":\"text-4xl font-bold text-white mb-2\",\"children\":\"Direct Competition: Advanced cSCC Treatment Market\"}],[\"$\",\"p\",null,{\"className\":\"text-2xl text-gray-300\",\"children\":\"Unloxcyt enters a market dominated by established PD-1 inhibitors with proven track records\"}]]}],[\"$\",\"div\",null,{\"className\":\"flex-1 min-h-0 overflow-hidden\",\"children\":[\"$\",\"div\",null,{\"className\":\"bg-slate-800/90 rounded-lg overflow-hidden h-full\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full h-full\",\"children\":[[\"$\",\"thead\",null,{\"children\":[\"$\",\"tr\",null,{\"className\":\"bg-slate-700 border-b-2 border-blue-400\",\"children\":[[\"$\",\"th\",null,{\"className\":\"text-2xl font-bold text-white p-4 text-left\",\"children\":\"Product\"}],[\"$\",\"th\",null,{\"className\":\"text-2xl font-bold text-white p-4 text-left\",\"children\":\"Company\"}],[\"$\",\"th\",null,{\"className\":\"text-2xl font-bold text-white p-4 text-left\",\"children\":\"Mechanism\"}],[\"$\",\"th\",null,{\"className\":\"text-2xl font-bold text-white p-4 text-left\",\"children\":\"Approval Year\"}],[\"$\",\"th\",null,{\"className\":\"text-2xl font-bold text-white p-4 text-left\",\"children\":\"Metastatic cSCC ORR\"}],[\"$\",\"th\",null,{\"className\":\"text-2xl font-bold text-white p-4 text-left\",\"children\":\"Key Advantage\"}],[\"$\",\"th\",null,{\"className\":\"text-2xl font-bold text-white p-4 text-left\",\"children\":\"Weakness\"}]]}]}],[\"$\",\"tbody\",null,{\"children\":[[\"$\",\"tr\",null,{\"className\":\"bg-slate-800 border-l-4 border-purple-400\",\"children\":[[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 font-bold text-purple-400\",\"children\":\"Unloxcyt\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"Sun Pharma\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"PD-L1 + ADCC\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"2024\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 font-bold text-green-400\",\"children\":\"47%\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 text-green-300\",\"children\":\"First PD-L1, ADCC activity\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 text-orange-300\",\"children\":\"Late market entry\"}]]}],[\"$\",\"tr\",null,{\"className\":\"bg-slate-700/50\",\"children\":[[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 font-bold\",\"children\":\"Keytruda\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"Merck\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"PD-1\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"2020\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"35%\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 text-green-300\",\"children\":\"Market leader, brand trust\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 text-orange-300\",\"children\":\"Lower ORR vs Unloxcyt\"}]]}],[\"$\",\"tr\",null,{\"className\":\"bg-slate-800\",\"children\":[[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 font-bold\",\"children\":\"Libtayo\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"Regeneron\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"PD-1\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"2018\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"Variable\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 text-green-300\",\"children\":\"First-mover, durability data\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 text-orange-300\",\"children\":\"Limited differentiation\"}]]}],[\"$\",\"tr\",null,{\"className\":\"bg-slate-700/50\",\"children\":[[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 font-bold\",\"children\":\"Opdivo\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"Bristol-Myers\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"PD-1\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"2014 (other)\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4\",\"children\":\"N/A for cSCC\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 text-green-300\",\"children\":\"Broad oncology portfolio\"}],[\"$\",\"td\",null,{\"className\":\"text-2xl p-4 text-orange-300\",\"children\":\"Not cSCC-specific\"}]]}]]}]]}]}]}],[\"$\",\"div\",null,{\"className\":\"flex-none bg-slate-800/90 p-6 rounded-lg border border-slate-700\",\"children\":[[\"$\",\"h3\",null,{\"className\":\"text-3xl font-bold text-white mb-4\",\"children\":\"Competitive Positioning Insights\"}],[\"$\",\"div\",null,{\"className\":\"grid grid-cols-1 gap-4\",\"children\":[[\"$\",\"div\",null,{\"className\":\"flex items-start gap-3\",\"children\":[[\"$\",\"svg\",null,{\"xmlns\":\"http://www.w3.org/2000/svg\",\"width\":20,\"height\":20,\"viewBox\":\"0 0 24 24\",\"fill\":\"none\",\"stroke\":\"currentColor\",\"strokeWidth\":2,\"strokeLinecap\":\"round\",\"strokeLinejoin\":\"round\",\"className\":\"lucide lucide-circle-check-big text-blue-400 mt-1\",\"children\":[[\"$\",\"path\",\"yps3ct\",{\"d\":\"M21.801 10A10 10 0 1 1 17 3.335\"}],[\"$\",\"path\",\"1pflzl\",{\"d\":\"m9 11 3 3L22 4\"}],\"$undefined\"]}],[\"$\",\"p\",null,{\"className\":\"text-xl\",\"children\":[[\"$\",\"strong\",null,{\"children\":\"Market Concentration:\"}],\" Top 3 brands captured 91% of global PD-1/PD-L1 sales in 2021\"]}]]}],[\"$\",\"div\",null,{\"className\":\"flex items-start gap-3\",\"children\":[[\"$\",\"svg\",null,{\"xmlns\":\"http://www.w3.org/2000/svg\",\"width\":20,\"height\":20,\"viewBox\":\"0 0 24 24\",\"fill\":\"none\",\"stroke\":\"currentColor\",\"strokeWidth\":2,\"strokeLinecap\":\"round\",\"strokeLinejoin\":\"round\",\"className\":\"lucide lucide-circle-check-big text-blue-400 mt-1\",\"children\":[[\"$\",\"path\",\"yps3ct\",{\"d\":\"M21.801 10A10 10 0 1 1 17 3.335\"}],[\"$\",\"path\",\"1pflzl\",{\"d\":\"m9 11 3 3L22 4\"}],\"$undefined\"]}],[\"$\",\"p\",null,{\"className\":\"text-xl\",\"children\":[[\"$\",\"strong\",null,{\"children\":\"Differentiation Opportunity:\"}],\" Unloxcyt's PD-L1 mechanism and ADCC provide legitimate clinical differentiation\"]}]]}],[\"$\",\"div\",null,{\"className\":\"flex items-start gap-3\",\"children\":[[\"$\",\"svg\",null,{\"xmlns\":\"http://www.w3.org/2000/svg\",\"width\":20,\"height\":20,\"viewBox\":\"0 0 24 24\",\"fill\":\"none\",\"stroke\":\"currentColor\",\"strokeWidth\":2,\"strokeLinecap\":\"round\",\"strokeLinejoin\":\"round\",\"className\":\"lucide lucide-circle-check-big text-blue-400 mt-1\",\"children\":[[\"$\",\"path\",\"yps3ct\",{\"d\":\"M21.801 10A10 10 0 1 1 17 3.335\"}],[\"$\",\"path\",\"1pflzl\",{\"d\":\"m9 11 3 3L22 4\"}],\"$undefined\"]}],[\"$\",\"p\",null,{\"className\":\"text-xl\",\"children\":[[\"$\",\"strong\",null,{\"children\":\"Market Size Justification:\"}],\" $1B+ U.S. cSCC market supports multiple successful competitors\"]}]]}]]}]]}]]}],[\"$\",\"div\",null,{\"className\":\"flex-none p-4 text-right\",\"children\":[\"$\",\"p\",null,{\"className\":\"text-xl text-gray-400\",\"children\":\"5\"}]}]]}]}],null],null],null]},[null,[\"$\",\"$L5\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\",\"pages\",\"children\",\"5\",\"children\"],\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L6\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"notFoundStyles\":\"$undefined\"}]],null]},[null,[\"$\",\"$L5\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\",\"pages\",\"children\"],\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L6\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"notFoundStyles\":\"$undefined\"}]],null]},[[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/8d323862949ffad9.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\"}]],[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"dark\",\"children\":[\"$\",\"body\",null,{\"className\":\"__className_f367f3 h-1080px w-1920px\",\"children\":[[\"$\",\"$7\",null,{\"fallback\":null,\"children\":[[\"$\",\"$L8\",null,{}],[\"$\",\"$L9\",null,{}]]}],[\"$\",\"$L5\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\"],\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L6\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"title\",null,{\"children\":\"404: This page could not be found.\"}],[\"$\",\"div\",null,{\"style\":{\"fontFamily\":\"system-ui,\\\"Segoe UI\\\",Roboto,Helvetica,Arial,sans-serif,\\\"Apple Color Emoji\\\",\\\"Segoe UI Emoji\\\"\",\"height\":\"100vh\",\"textAlign\":\"center\",\"display\":\"flex\",\"flexDirection\":\"column\",\"alignItems\":\"center\",\"justifyContent\":\"center\"},\"children\":[\"$\",\"div\",null,{\"children\":[[\"$\",\"style\",null,{\"dangerouslySetInnerHTML\":{\"__html\":\"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}\"}}],[\"$\",\"h1\",null,{\"className\":\"next-error-h1\",\"style\":{\"display\":\"inline-block\",\"margin\":\"0 20px 0 0\",\"padding\":\"0 23px 0 0\",\"fontSize\":24,\"fontWeight\":500,\"verticalAlign\":\"top\",\"lineHeight\":\"49px\"},\"children\":\"404\"}],[\"$\",\"div\",null,{\"style\":{\"display\":\"inline-block\"},\"children\":[\"$\",\"h2\",null,{\"style\":{\"fontSize\":14,\"fontWeight\":400,\"lineHeight\":\"49px\",\"margin\":0},\"children\":\"This page could not be found.\"}]}]]}]}]],\"notFoundStyles\":[]}]]}]}]],null],null],\"couldBeIntercepted\":false,\"initialHead\":[null,\"$La\"],\"globalErrorComponent\":\"$b\",\"missingSlots\":\"$Wc\"}]\n"])</script><script>self.__next_f.push([1,"a:[[\"$\",\"meta\",\"0\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1\"}],[\"$\",\"meta\",\"1\",{\"charSet\":\"utf-8\"}],[\"$\",\"title\",\"2\",{\"children\":\"Unloxcyt Market Survey - Interactive Presentation\"}],[\"$\",\"meta\",\"3\",{\"name\":\"description\",\"content\":\"Comprehensive market analysis of Cosibelimab-ipdl for advanced cSCC\"}],[\"$\",\"meta\",\"4\",{\"name\":\"next-size-adjust\"}]]\n4:null\n"])</script></body></html>